Category survey

Dominantly Inherited Alzheimers Network Trials Unit – Adaptive Prevention Trial Investments > €500k United States of America Alzheimer’s disease & other dementias 2016    

Reducing Agitation in Dementia Patients at Home: The Customized Activity Trial Investments > €500k United States of America Alzheimer’s disease & other dementias 2016    

Olfactory deficits and donepezil treatment in cognitively impaired elderly Investments > €500k United States of America Alzheimer’s disease & other dementias 2016    

Aerobic Exercise in Alzheimers Disease: Cognition and Hippocampal Volume Effects Investments > €500k United States of America Alzheimer’s disease & other dementias 2016    

Benfotiamine in Alzheimers Disease: A pilot study Investments > €500k United States of America Alzheimer’s disease & other dementias 2016    

Cognitive training and practice effects in MCI Investments > €500k United States of America Alzheimer’s disease & other dementias 2016    

Apathy in Alzheimers Disease Methyphenidate Trial II (ADMET II) Investments > €500k United States of America Alzheimer’s disease & other dementias 2016    

The VETSA Longitudinal MRI Twin Study of Aging Investments > €500k United States of America Alzheimer’s disease & other dementias 2016    

Amyloid Pathology and Cognition in Normal Elderly Investments > €500k United States of America Alzheimer’s disease & other dementias 2016    

Cocoa Supplement and Multivitamin Outcomes Study in the Mind (COSMOS-Mind) Investments > €500k United States of America Alzheimer’s disease & other dementias 2016    

Characterizing the Behavior Profile of Healthy Cognitive Aging Investments > €500k United States of America Alzheimer’s disease & other dementias 2016    

Biological predictors of brain aging trajectories Investments > €500k United States of America Alzheimer’s disease & other dementias 2016    

Menopausal Vasomotor Symptoms and Brain Aging in Women Investments > €500k United States of America Alzheimer’s disease & other dementias 2016    

Aging Brain, Cognition, and Dopamine Investments > €500k United States of America Alzheimer’s disease & other dementias 2016    

Pathophysiology of postoperative delirium and the use of biomimetic sleep as a treatment strategy in the CSICU Investments > €500k United States of America Alzheimer’s disease & other dementias 2016    

Neural and Biochemical Mechanisms of Cognitive Aging Investments > €500k United States of America Alzheimer’s disease & other dementias 2016    

Exploring Cognitive Aging Using Refernce Ability Neural Networks Investments > €500k United States of America Alzheimer’s disease & other dementias 2016    

Augmenting Cognitive Training in Older Adults – The ACT Grant Investments > €500k United States of America Alzheimer’s disease & other dementias 2016    

MIDLIFE COGNITIVE CHANGE AND RISK OF COGNITIVE DECLINE Investments > €500k United States of America Alzheimer’s disease & other dementias 2016    

Imaging of Cognition, Learning and Memory in Aging Investments > €500k United States of America Alzheimer’s disease & other dementias 2016    

Omega 3 pufas for the vascular component of age-related cognitive decline. Investments > €500k United States of America Alzheimer’s disease & other dementias 2016    

Investigating Gains in Neurocognition in an Intervention Trial of Exercise Investments > €500k United States of America Alzheimer’s disease & other dementias 2016    

Effects of chronic inflammation on brain structure and function Investments > €500k United States of America Alzheimer’s disease & other dementias 2016    

Connectomics of Brain Aging and Dementia Investments > €500k United States of America Alzheimer’s disease & other dementias 2016    

Connectomic imaging in familial and sporadic frontotemporal degeneration Investments > €500k United States of America Alzheimer’s disease & other dementias 2016    

Alzheimers Disease Connectome Project Investments > €500k United States of America Alzheimer’s disease & other dementias 2016    

Mapping interindividual variation in the aging connectome Investments > €500k United States of America Alzheimer’s disease & other dementias 2016    

Innovating Tablet-Based Cognitive Assessment for CNS Disorders of Aging Investments > €500k United States of America Alzheimer’s disease & other dementias 2016    

African AMERICANS Fighting Alzheimers In Midlife Investments > €500k United States of America Alzheimer’s disease & other dementias 2016    

Cardiac function as a mechanism for maladaptive brain aging Investments > €500k United States of America Alzheimer’s disease & other dementias 2016    

Cardiac function as a mechanism for maladaptive brain aging Investments > €500k United States of America Alzheimer’s disease & other dementias 2016    

Health Disparities in Alzheimers Disease Among Mexican Americans Investments > €500k United States of America Alzheimer’s disease & other dementias 2016    

Pathways to Brain Health for African Americans: A Community-Based Participatory Research Study Investments > €500k United States of America Alzheimer’s disease & other dementias 2016    

Web-enabled social interaction to delay cognitive decline among seniors with MCI: Phase I Investments > €500k United States of America Alzheimer’s disease & other dementias 2016    

Dissociating Intrinsic and Extrinsic Motor Learning in Alzheimers Disease Investments > €500k United States of America Alzheimer’s disease & other dementias 2016    

Eye Determinants of Cognition (EyeDOC) Study Investments > €500k United States of America Alzheimer’s disease & other dementias 2016    

Regulatory Approval of the OLFACT Test Battery Investments > €500k United States of America Alzheimer’s disease & other dementias 2016    

Genetic Epidemiology of Cognitive Decline in an Aging Population Sample Investments > €500k United States of America Alzheimer’s disease & other dementias 2016    

Effects of Aging on Visual Memory: Neuroimaging Studies Investments > €500k United States of America Alzheimer’s disease & other dementias 2016    

Omega-3, isoflavones & amyloid deposition in cognitively normal elderly Japanese Investments > €500k United States of America Alzheimer’s disease & other dementias 2016    

Insulin Resistance and Accelerated Cognitive Aging Investments > €500k United States of America Alzheimer’s disease & other dementias 2016    

Adiposity, Inflammation and Neurocognitive Decline in African Americans Investments > €500k United States of America Alzheimer’s disease & other dementias 2016    

High-resolution imaging of hippocampal mechanisms in age-related memory decline. Investments > €500k United States of America Alzheimer’s disease & other dementias 2016    

Exceptional Cognitive Aging: Neuropsychologic, Anatomic and Pathologic Correlates Investments > €500k United States of America Alzheimer’s disease & other dementias 2016    

High-Resolution Structural and Functional Brain Imaging of Medial Temporal Lobe i Investments > €500k United States of America Alzheimer’s disease & other dementias 2016    

The impact of non-amyloid processes on cognitive aging Investments > €500k United States of America Alzheimer’s disease & other dementias 2016    

Noninvasive Stimulation to Improve Hippocampal-Dependent Memory in Older Adults Investments > €500k United States of America Alzheimer’s disease & other dementias 2016    

Deep Brain Stimulation for Alzheimers Disease Investments > €500k United States of America Alzheimer’s disease & other dementias 2016    

Hypertension angiotensin receptor blockers and cognition: effects and mechanism Investments > €500k United States of America Alzheimer’s disease & other dementias 2016    

Effect of Aerobic Exercise on Alzheimers Pathophysiology in Preclinical AD Investments > €500k United States of America Alzheimer’s disease & other dementias 2016